Wooree Bio Co.,Ltd Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	1,083,198	1,237,198	1,263,944	1,355,056	1,543,312	1,623,383
Other Revenue	-	-	-0	-	-	0
Revenue	1,083,198	1,237,198	1,263,944	1,355,056	1,543,312	1,623,383
Revenue Growth (YoY)	-14.28%	-2.12%	-6.72%	-12.20%	-4.93%	-2.94%
Cost of Revenue	985,740	1,119,187	1,148,606	1,241,417	1,427,899	1,523,846
Gross Profit	97,458	118,012	115,337	113,639	115,412	99,537
Selling, General & Admin	80,616	84,804	74,363	65,396	57,472	47,617
Research & Development	11,449	11,439	8,398	7,019	7,382	6,631
Amortization of Goodwill & Intangibles	375.18	375.98	315.99	372.6	530.3	935.31
Other Operating Expenses	1,437	1,548	1,350	1,884	1,274	1,376
Operating Expenses	100,659	102,812	89,355	79,398	72,995	62,095
Operating Income	-3,201	15,200	25,982	34,241	42,417	37,442
Interest Expense	-6,084	-5,402	-6,052	-4,948	-4,438	-6,468
Interest & Investment Income	3,706	4,365	3,834	1,632	427.15	320.28
Earnings From Equity Investments	34.54	-79.77	-190.83	-123.76	-184.23	13.08
Currency Exchange Gain (Loss)	2,752	8,637	-1,908	-116.95	4,510	-2,077
Other Non Operating Income (Expenses)	4,345	3,829	250.77	1,224	2,566	3,930
EBT Excluding Unusual Items	1,552	26,548	21,917	31,909	45,298	33,161
Gain (Loss) on Sale of Investments	-	-	-	-	188.71	-1,865
Gain (Loss) on Sale of Assets	852.06	317.61	-187.34	117.01	-206.37	-9,019
Asset Writedown	-2,193	-2,327	-	-	-	-52.45
Pretax Income	211.16	24,539	21,729	32,026	45,281	22,224
Income Tax Expense	13,786	16,312	2,783	6,900	1,239	5,241
Earnings From Continuing Operations	-13,575	8,227	18,946	25,126	44,041	16,983
Net Income to Company	-13,575	8,227	18,946	25,126	44,041	16,983
Minority Interest in Earnings	-414.18	-3,483	-3,365	-3,304	-10,886	-141.65
Net Income	-13,989	4,743	15,581	21,822	33,156	16,841
Net Income to Common	-13,989	4,743	15,581	21,822	33,156	16,841
Net Income Growth	-	-69.56%	-28.60%	-34.18%	96.87%	271.64%
Shares Outstanding (Basic)	47	47	47	46	44	44
Shares Outstanding (Diluted)	47	47	47	46	48	45
Shares Change (YoY)	-0.59%	0.13%	1.95%	-2.87%	5.70%	-
EPS (Basic)	-296.33	100.50	330.98	469.36	750.13	385.66
EPS (Diluted)	-296.33	100.00	329.00	469.00	702.06	376.03
EPS Growth	-	-69.60%	-29.85%	-33.20%	86.70%	253.57%
Free Cash Flow	6,167	-45,711	16,018	30,085	38,588	52,167
Free Cash Flow Per Share	130.63	-963.15	337.94	647.10	806.13	1151.92
Gross Margin	9.00%	9.54%	9.13%	8.39%	7.48%	6.13%
Operating Margin	-0.30%	1.23%	2.06%	2.53%	2.75%	2.31%
Profit Margin	-1.29%	0.38%	1.23%	1.61%	2.15%	1.04%
Free Cash Flow Margin	0.57%	-3.69%	1.27%	2.22%	2.50%	3.21%
EBITDA	24,028	42,731	57,832	70,435	77,974	76,287
EBITDA Margin	2.22%	3.45%	4.58%	5.20%	5.05%	4.70%
D&A For EBITDA	27,229	27,531	31,850	36,194	35,557	38,845
EBIT	-3,201	15,200	25,982	34,241	42,417	37,442
EBIT Margin	-0.29%	1.23%	2.06%	2.53%	2.75%	2.31%
Effective Tax Rate	6528.56%	66.47%	12.81%	21.54%	2.74%	23.58%
Advertising Expenses	-	8,170	9,177	8,633	3,642	246.06

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.